Management of Narcolepsy and excessive Daytime Sleepines in Obstructive Sleep Apnea
August 09, 2017
In this program, sleep experts including Richard Bogan, MD (Chair), and Suresh Kotagal, MBBS provide valuable insights and best practices for diagnosing and treating narcolepsy in children and adults. Case Studies and in depth participation by Atul Malhotra, MD, Patrick Strollo Jr., MD, and Lisa Collins, RRT, RPSGT, RCP
CME 2.00 Credits
LDL Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk: EMERGING INSIGHTS
April 08, 2017
In this program, Dr. Lynn Braun and Dr. Michael Miller present lectures and case studies addressing the management of atherosclerotic cardiovascular disease along with best practices and treatment options.
CE | CME 1.00 Credits
The Perfect Storm of Heart Failure and Diabetes: Insights into Pathophysiology and Evidence-Based Treatment Strategies
November 08, 2016
In this educational initiative, experts will address the needs of cardiologists for 1) a grasp of the relationship between DM and HF and the pathophysiology of HF in DM, 2) an explanation of clinical evidence for HF drugs in patients with DM, and 3) an assessment of the profiles of traditional and newer antidiabetic agents in patients with/at risk for cardiovascular disease and interpretation of heart failure-related outcomes.
CME 1.00 Credits
Optimizing Outcomes in the Management of Narcolepsy and Obstructive Sleep Apnea
October 25, 2016
In this program, Michael Thorpy, MD and Phyllis Zee, MD, provide state-of-the-art lectures, a stimulating panel discussion, and a provocative case study to address the challenges in the diagnosis of narcolepsy.
CME 0.75 Credits
Best Practices for Managing Narcolepsy and Obstructive Sleep Apnea: Evidence-Based Strategies and Solutions
June 13, 2016
Thomas Scammell, MD (Chair), Richard Bogan, MD, Michael Thorpy, MD, and Phyllis Zee, MD, PhD address the challenges in the diagnosis of narcolepsy, identify best practices, and assess current and emerging strategies for treatment of EDS in OSA.
CME 2.00 Credits
Optimizing Management of Recurrent Angina after PCI
May 08, 2015
Deepak Bhatt, MD, MPH, FSCAI (Chair); Duane Pinto, MD, FSCAI and Peter Stone, MD, MPH conduct a state-of-the-art discussion and case study on recurrent angina after PCI
No Credit Available
Demystifying Hypertriglyceridemia: Taking a Closer Look at Pathophysiology, Etiology, and Treatment
April 29, 2015
Eliot Brinton, MD and Terry Jacobson, MD discuss the pathophysiology, etiology, and treatment of hypertriglyceridemia.
No Credit Available
The Dynamics of In-Hospital and Post-Discharge ACS Management with Oral Antiplatelet Therapies
March 14, 2015
Jeffrey Anderson, MD, Van de Werf,MD and Marc Sabatine MD, discuss timing/location, dosing, duration of oral antiplatelet therapies, clinical trials, and guidelines.
No Credit Available
New Pathways to GLYCEMIC CONTROL: Focus on the Kidney
October 28, 2014
Presentations by Jay Shubrook, DO (Chair), Eugene Cersosimo, MD, PhD, and Robert Henry, MD. discussing the role of glucose regulation and SGLT 2 inhibitors in antihyperglycemic therapy
No Credit Available
Unmasking Narcolepsy: Diagnostic and Therapeutic Strategies
September 19, 2014
Michael Thorpy, MD (Chair) and Allen Boone, RPSGT, RST, CCRC discussion of diagnosis, testing, treatment options and associated clinical efficacy and safety data in narcolepsy management.
No Credit Available
Oral Antiplatelet Therapies for Acute Coronary Syndromes: State of the Art Management
September 15, 2014
Deepak Bhatt, MD, MPH (Chair), Paul Gurbel, MD, Robert Harrington, MD, Ajay Kirtane, MD, SM, Manesh Patel, MD, Marc Sabatine, MD, MPH and Philippe Gabriel Steg, MD discuss contemporary use of antiplatelet therapy and ACS management in lectures and cases.
No Credit Available
Clinical Decision-Making in Narcolepsy Management: State Of The Art
August 19, 2014
Michael Thorpy, MD (Chair); Emmanuel Mignot, MD, PhD; Rafael Pelayo, MD; A. Thomas Perkins, MD, PhD. and Todd Swick, MD. review DSM-5 definitions, ICSD-3 guidelines, treatment options, and challenges in the management of narcolepsy in the pediatric population.
No Credit Available